iPatientAxis (ChartFill DBA), announces the resignation of Michael Margiotta as director, Chairman and Chief Executive Officer, and his decision to divest his stock holdings.
Mr. Margiotta said, “As founder of iPatientAxis, I am tremendously proud of this team and the incredible company that we have built over the last few years. Our organization now services 32 countries, supporting more than 400 clinical research facilities each day. While our business has never been stronger, I have decided that it is in the best interest of the company to step down as CEO and chairman.”
“Although Mr. Margiotta has done a tremendous job building and leading this organization, he has chosen to resign and the Board and I thank him for all his hard work and dedication” says newly appointed Chairman of the Board of Directors, John Friend MD. “iPatientAxis has solidified a unique place in the market by providing a suite of services that streamline patient identification and increase enrollment for clinical trials.”
Ryan McFarlane, newly appointed President & CEO, “It is an incredible honor to lead iPatientAxis during this exciting time in the company’s history as it continues to outperform its financial projections by impressive double-digit growth year over year. I will continue to advance the organization that has thrived under Mr. Margiotta’s leadership. We have an exceptionally talented team and will continue investing in the business to ensure that we provide our clients with leading customer focus in the clinical trial services.” Mr. McFarlane joined iPatientAxis late 2019 as Chief Business Officer with over 20 years’ experience in the pharmaceutical and clinical trial space.
The iPatientAxis board regularly evaluates its composition to ensure it includes the appropriate skills, experience, and perspective necessary to drive growth for all its shareholders. Therefore, the board has appointed Maria Logan and Kelly Smith to play a vital part in assisting in the rapid growth of the organization.
Maria, an Irish citizen and CEO of her own company of 20 years will help grow our Irish sub-subsidiary (iPatientAxis EU) based in Dublin. Maria has established connections in the Irish Government and Healthcare arenas, specifically around the Healthcare and Technology Grants iPatientAxis EU is currently exploring.
Kelly has 12 years of operational industry knowledge and is currently Director of Operations & Customer Engagement at iPatientAxis. Kelly is well poised to impact the scalability of the organization as it continues along its positive growth curve. Kelly will enhance the Voice of the Customer program and be part of building the roadmap for additional customers, partners and acquisitions.
iPatientAxis is the global leader in clinical trial medical record aggregation, analytics and pre-validation services. Uniquely positioned to change the paradigm in the global clinical trial market, iPatientAxis combines real-world clinical data with a patented platform to streamline and automate both patient and site identification. iPatientAxis ensures that trials meet their enrollment goals without incurring the unexpected expenses of adding additional sites or costly delays. To learn more, visit: www.ipatientaxis.com. For more information please email: email@example.com